Here we provide drug discovery services to multiple partners and these collaborations cover the spectrum from small, single discipline projects to fully integrated drug discovery projects.  We have worked across all major druggable target classes and therapeutic areas and a range of rare and neglected diseases with in depth experience in CNS and oncology.  Our work is mainly based around small molecules and we have recently increased our work in the area of large molecules.  We are proud of our record of achievement.  Together with our sister site in Harlow, we have run around 300 small molecule projects in H2L and LO and invented over 80 pre-clinical candidates for our partner organisations.  

​

This facility was acquired by CRL in April 2014 from Galapagos. Galapagos acquired BioFocus in 2005 and continued to have it operate under the BioFocus name.  BioFocus was a CRO (Contract Research Organisation) focused in early stage in vitro drug discovery.  It was the very first company to be established at the Science Park in Saffron Walden when it was founded in 2000.  We still have 5 of the original 22 staff that joined BioFocus in 2000!